Clinical Trial

The U.S. PDA Registry

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to demonstrate the continued safety and efficacy in a real-world setting of transcatheter device closure of the PDA in premature infants less than 2kg in weight at the time of device implant using the Amplatzer Piccolo Occluder device and other devices performed in the USA.
Trial Details
NCT Number NCT04205877
Lead Sponsor Le Bonheur Children's Hospital
Collaborators: Abbott
Conditions Ductus Arteriosus, Patent
Enrollment 5,000 participants
Start Date 2020-01-01
Primary Completion 2030-01-01 (estimated)
Study Completion 2031-12-01 (estimated)
Updated on ClinicalTrials.gov 2019-12-20